1. Home
  2. KALV vs PKST Comparison

KALV vs PKST Comparison

Compare KALV & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.12

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Logo Peakstone Realty Trust

PKST

Peakstone Realty Trust

HOLD

Current Price

$20.80

Market Cap

574.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
PKST
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
574.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
PKST
Price
$16.12
$20.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$30.00
$17.50
AVG Volume (30 Days)
1.3M
702.8K
Earning Date
03-11-2026
02-19-2026
Dividend Yield
N/A
1.92%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,426,000.00
$221,496,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$204.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.03
52 Week Low
$8.74
$10.35
52 Week High
$19.00
$20.85

Technical Indicators

Market Signals
Indicator
KALV
PKST
Relative Strength Index (RSI) 54.89 92.35
Support Level $15.22 $13.74
Resistance Level $16.16 $14.33
Average True Range (ATR) 0.88 0.39
MACD -0.01 0.51
Stochastic Oscillator 76.95 99.38

Price Performance

Historical Comparison
KALV
PKST

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: